Completed PHASE3 INTERVENTIONAL 2-arm NCT00436969

ORTHOVISC Shoulder Osteoarthritis Study

A Comparison of Orthovisc® to Corticosteroid Injection in Shoulder Osteoarthritis: Orthovisc Randomized Clinical Trial

Sponsor: DePuy Mitek

Updated 10 times since 2017 Last updated: Jan 27, 2017 Started: Dec 31, 2006 Primary completion: Feb 28, 2010 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Glenohumeral Osteoarthritis, this trial is completed. The trial is conducted by DePuy Mitek and has accumulated 10 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2023 — Jul 2024 [monthly]

Completed PHASE3
Dec 2022 — Jan 2023 [monthly]

Completed PHASE3

▶ Show 5 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
May 2017 — Jun 2018 [monthly]

Completed PHASE3
Feb 2017 — May 2017 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

DePuy Mitek

Data source: DePuy Mitek

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Charlottesville, United States , Coral Gables, United States , Encinitas, United States , Fresno, United States , Gulf Breeze, United States , Houston, United States , New Orleans, United States , New York, United States , Saint Clair Shores, United States , State College, United States and 3 more locations